Therefore, ACE2-deficient mice provide a suitable model for assessing the pathophysiological relevance of NAFLD and represent an excellent tool to investigate new therapeutic strategies for MetS as well as associating disorders. Here, ACE2 is linked to metabolic dysfunction-associated steatotic liver disease.